Further evaluation with fluorescence in situ hybridisation (FISH) panel showed SS18-SSX2 fusion, which favoured a diagnosis of synovial sarcoma. On subsequent review of the histopathology, the tumour was classified as a poorly differentiated synovial sarcoma. The gene discussed is SS18; the disease is synovial sarcoma.